Pharmaceutical composition comprising amniotic fluid stem cell spheres and use thereof for treating urinary incontinence

Abstract

The invention discloses a pharmaceutical composition containing amniotic fluid stem cell spheres and application of the pharmaceutical composition in treating urinary incontinence. In particular to application of amniotic fluid stem cell spheres to preparation of a composition or a pharmaceutical composition for treating urinary incontinence, and the amniotic fluid stem cell spheres can further contain hyaluronic acid.

Description

technical field [0001] The present invention relates to a method for treating urinary incontinence, which includes giving patients an effective amount of amniotic fluid stem cells; specifically, giving patients an effective amount of amniotic fluid stem cells and hyaluronic acid. Background technique [0002] As a routine prenatal diagnosis, amniotic fluid cells can detect whether the fetus has chromosomal abnormalities. In addition, studies have shown that some small nucleated cells with the characteristics of hematopoietic precursor cells can be identified in the amniotic fluid before 12 weeks of gestation, and it is speculated that these cells may come from the yolk sac. From 2004 to 2006, it was reported that the existence of another group of stem cells in amniotic fluid could be successfully isolated and identified. These amniotic fluid stem cells have been confirmed to exhibit specific biomarkers of mesenchymal stem cells and neural stem cells at the same time, and hav...

AI Technical Summary

Problems solved by technology

The effect of physical rehabilitation is limited. Although the success rate of surgical treatment is high, the effect is poor in the male group, and some patients will resist surgical treatment

Images